Zobrazeno 41 - 50
of 211
pro vyhledávání: '"Marco L. Davila"'
Autor:
Brian C. Betts, Said M. Sebti, Claudio Anasetti, Bruce R. Blazar, Harshani R. Lawrence, Nicholas J. Lawrence, Shernan G. Holtan, Elizabeth M. Sagatys, Michael L. Nieder, Marco L. Davila, Rawan G. Faramand, Lia Perez, Farhad Khimani, Taiga Nishihori, Nelli Bejanyan, Asmita Mishra, Jongphil Kim, Hany Elmariah, Kelly Walton, Joseph Pidala
Impact of JAK2/mTOR blockade on human T cell responses toward CMV, EBV, Influenza, and tetanus stimulation. A, B) Graphs show the recall proliferation of CD4+ and CD8+ T cell proliferation in response to CEFT peptides. C, D) Graph shows the frequency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b7358ce6d528eff3f94fa64d4d0941b
https://doi.org/10.1158/1078-0432.22479066.v1
https://doi.org/10.1158/1078-0432.22479066.v1
Autor:
Christoph K. Stein-Thoeringer, Neeraj Y. Saini, Eli Zamir, Viktoria Blumenberg, Maria-Luisa Schubert, Uria Mor, Matthias A. Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayase, Roman Rohrbach, Chia-Chi Chang, Lauren McDaniel, Ivonne Flores, Rogier Gaiser, Matthias Edinger, Daniel Wolff, Martin Heidenreich, Paolo Strati, Ranjit Nair, Dai Chihara, Luis E. Fayad, Sairah Ahmed, Swaminathan P. Iyer, Raphael E. Steiner, Preetesh Jain, Loretta J. Nastoupil, Jason Westin, Reetakshi Arora, Michael L. Wang, Joel Turner, Meghan Menges, Melanie Hidalgo-Vargas, Kayla Reid, Peter Dreger, Anita Schmitt, Carsten Müller-Tidow, Frederick L. Locke, Marco L. Davila, Richard E. Champlin, Christopher R. Flowers, Elizabeth J. Shpall, Hendrik Poeck, Sattva S. Neelapu, Michael Schmitt, Marion Subklewe, Michael D. Jain, Robert R. Jenq, Eran Elinav
Publikováno v:
Nat Med
Increasing evidence suggests that the gut microbiome may modulate the efficacy of cancer immunotherapy. In a B cell-lymphoma patient cohort from five centers in Germany and the United States (Germany, N=66; US, N=106, Total, N=172), we demonstrate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b678db32d5c1d49ee86ffd70077e4ff
https://europepmc.org/articles/PMC10121864/
https://europepmc.org/articles/PMC10121864/
Autor:
Shernan G. Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A. Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L. MacMillan, Daniel J. Weisdorf, Martin Felices, Jeffrey S. Miller, Bruce R. Blazar, Marco L. Davila, Brian C. Betts
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
Purpose:Acute and chronic GVHD remain major causes of transplant-related morbidity and mortality (TRM) after allogeneic hematopoietic cell transplantation (alloHCT). We have shown CD83 chimeric antigen receptor (CAR) T cells prevent GVHD and kill mye
Autor:
Marco L, Davila, Renier J, Brentjens
Publikováno v:
Nature cancer. 3(12)
Autor:
Marco L. Davila, Michael Nieder, Hien Liu, Mukta Arora, Frederick L. Locke, Stephanie J. Lee, Asmita Mishra, Nelli Bejanyan, Jongphil Kim, Joseph Pidala, Michael D. Jain, Brian C. Betts, Rebecca Gonzalez, Leonel Ochoa, Ernesto Ayala, Rawan Faramand, Claudio Anasetti, Farhad Khimani, Taiga Nishihori, Hugo F. Fernandez, Mohamed A. Kharfan-Dabaja, Aleksandr Lazaryan, Omar Alexis Castaneda Puglianini, Ariel Perez Perez, Lia Perez, Hany Elmariah, Karlie Balke, Melissa Alsina
Publikováno v:
Blood Advances
Key Points Ofatumumab with glucocorticoid therapy for cGVHD resulted in 62.5% ORR at 6 months and 53% FFS at 12 months.Safety was observed with ofatumumab plus glucocorticoid for initial therapy.
Visual Abstract
Standard initial therapy of
Visual Abstract
Standard initial therapy of
Autor:
Semira Sheikh, Sepideh Mokhtari, Jeffrey A. Silverman, Kayla Reid, Rawan Faramand, Marco L. Davila, Norman Franke, Frederick L. Locke, Michael D. Jain, Daniel Wong, John G. Kuruvilla
Publikováno v:
eJHaem. 3:223-227
Autor:
Michael Nieder, Doris K. Hansen, Claudio Anasetti, Nelli Bejanyan, Ariel Perez Perez, Leonel Ochoa, Frederick L. Locke, Erin Dean, Jongphil Kim, Joseph Pidala, Aleksandr Lazaryan, Peter Ranspach, Rawan Faramand, Hein Liu, Hany Elmariah, Taiga Nishihori, Lia Perez, Michael D. Jain, Junmin Whiting, Asmita Mishra, Melissa Alsina, Farhad Khimani, Marco L. Davila
Publikováno v:
Transplantation and Cellular Therapy. 27:940-948
Post-transplantation cyclophosphamide (PTCy) is being increasingly used for graft-versus-host disease (GVHD) prophylaxis after allogeneic hematopoietic cell transplantation (allo-HCT) across various donor types. However, immune reconstitution and inf
Autor:
Doris K Hansen, Lauren Peres, Ciara Freeman, Omar Castaneda, Rawan G Faramand, Laura Oswald, Kayla Reid, Gabe De Avila, Brandon Jamaal Blue, Ariel Grajales, Leonel Ochoa, Alexandria M Shrewsbury, William Doyle, Cole T. Powell, Turab Mohammed, Rebecca Gonzalez, Jennifer Logue, Farhad Khimani, Hany Elmariah, Michael D Jain, Hien Liu, Jason Brayer, Taiga Nishihori, Kenneth Shain, Rachid Baz, Melissa Alsina, Marco L. Davila, Frederick L. Locke
Publikováno v:
Transplantation and Cellular Therapy. 29:S197-S198
Autor:
Razan Mohty, Dimitrios Drekolias, Lauren Peres, Ciara Freeman, Omar Castaneda, Rawan G Faramand, Laura Oswald, Kayla Reid, Gabe De Avila, Brandon Jamaal Blue, Ariel Grajales, Turab Mohammed, Jose Ochoa-Bayona, Alexandria M Shrewsbury, William Doyle, Rebecca Gonzalez, Jennifer Logue, Hany Elmariah, Michael D Jain, Hien Liu, Jason Brayer, Kenneth Shain, Rachid Baz, Melissa Alsina, Taiga Nishihori, Marco L. Davila, Frederick L. Locke, Doris K Hansen
Publikováno v:
Transplantation and Cellular Therapy. 29:S215-S216
Autor:
Ning Dong, Lucía Rubio Lopes-Garcia, David Viñal, Christina Bachmeier, Bijal D. Shah, Taiga Nishihori, Farhad Khimani, Marco L. Davila, Aleksandr Lazaryan, Javier Pinilla-Ibarz, Frederick L. Locke, Michael D. Jain, Julio C. Chavez
Publikováno v:
Transplantation and Cellular Therapy. 29:349.e1-349.e8